XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2020   66,432      
Beginning balance at Dec. 31, 2020 $ 1,355,056 $ 665 $ 4,260,443 $ (5,505) $ (2,900,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   294      
Vesting of restricted stock units 0 $ 3 (3)    
Exercise of stock options (in shares)   207      
Exercise of stock options 1,219 $ 2 1,217    
Purchase of common stock under ESPP (in shares)   67      
Purchase of common stock under ESPP 1,707 $ 1 1,706    
Stock-based compensation 36,090   36,090    
Issuance of unrestricted stock awards to settle accrued employee compensation (in shares)   422      
Issuance of unrestricted stock awards to settle accrued employee compensation 12,013 $ 4 12,009    
Other comprehensive income 56     56  
Net loss (205,808)       (205,808)
Ending balance, shares (in shares) at Mar. 31, 2021   67,422      
Ending balance at Mar. 31, 2021 1,200,333 $ 675 4,311,462 (5,449) (3,106,355)
Beginning balance (in shares) at Dec. 31, 2020   66,432      
Beginning balance at Dec. 31, 2020 1,355,056 $ 665 4,260,443 (5,505) (2,900,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (272)        
Net loss (447,510)        
Ending balance, shares (in shares) at Jun. 30, 2021   67,551      
Ending balance at Jun. 30, 2021 984,561 $ 676 4,337,719 (5,777) (3,348,057)
Beginning balance (in shares) at Mar. 31, 2021   67,422      
Beginning balance at Mar. 31, 2021 1,200,333 $ 675 4,311,462 (5,449) (3,106,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   127      
Vesting of restricted stock units 0 $ 1 (1)    
Exercise of stock options (in shares)   2      
Exercise of stock options 36   36    
Stock-based compensation 26,222   26,222    
Other comprehensive income (328)     (328)  
Net loss (241,702)       (241,702)
Ending balance, shares (in shares) at Jun. 30, 2021   67,551      
Ending balance at Jun. 30, 2021 $ 984,561 $ 676 4,337,719 (5,777) (3,348,057)
Beginning balance (in shares) at Dec. 31, 2021 71,115 71,115      
Beginning balance at Dec. 31, 2021 $ 374,277 $ 711 4,096,402 (2,911) (3,719,925)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   310      
Vesting of restricted stock units 0 $ 3 (3)    
Exercise of stock options (in shares)   1      
Exercise of stock options 1   1    
Stock-based compensation 12,681   12,681    
Issuance of unrestricted stock awards to settle accrued employee compensation (in shares)   12      
Other comprehensive income (1,548)     (1,548)  
Net loss (122,152)       (122,152)
Ending balance, shares (in shares) at Mar. 31, 2022   71,438      
Ending balance at Mar. 31, 2022 $ 263,259 $ 714 4,109,081 (4,459) (3,842,077)
Beginning balance (in shares) at Dec. 31, 2021 71,115 71,115      
Beginning balance at Dec. 31, 2021 $ 374,277 $ 711 4,096,402 (2,911) (3,719,925)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 2        
Other comprehensive income $ (1,505)        
Net loss $ (222,290)        
Ending balance, shares (in shares) at Jun. 30, 2022 73,551 73,551      
Ending balance at Jun. 30, 2022 $ 180,116 $ 735 4,126,012 (4,416) (3,942,215)
Beginning balance (in shares) at Mar. 31, 2022   71,438      
Beginning balance at Mar. 31, 2022 263,259 $ 714 4,109,081 (4,459) (3,842,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   60      
Vesting of restricted stock units 0 $ 1 (1)    
Exercise of stock options (in shares)   1      
Exercise of stock options 1   1    
Stock-based compensation 8,908   8,908    
Issuance of unrestricted stock awards to settle accrued employee compensation (in shares)   2,052      
Issuance of unrestricted stock awards to settle accrued employee compensation 8,043 $ 20 8,023    
Other comprehensive income 43     43  
Net loss $ (100,138)       (100,138)
Ending balance, shares (in shares) at Jun. 30, 2022 73,551 73,551      
Ending balance at Jun. 30, 2022 $ 180,116 $ 735 $ 4,126,012 $ (4,416) $ (3,942,215)